Commentary: The role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria

BMC Urology

Volumn 9, Issue 1, 2009, Pages

  Trivedi, Deep ^a   Messing, Edward M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER BIOPSY; BLADDER CANCER; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; CYTOLOGY; HEMATURIA; HUMAN; INTRAVENOUS PYELOGRAPHY; URINALYSIS; EDITORIAL; PATHOLOGY; URINE;

HEMATURIA; HUMANS; URINE;

EID: 70349667017     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-9-13     Document Type: Article

References (13)

1. "Usefulness of urine cytology in the diagnosis of bladder cancer: relationship with pathologic findings". G Castro F Fernandez M Corriente, Acas Urol Esp 2008 32 9 904 907
2. "Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association Best Practice Policy-Part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation and followup.". GD Grossfeld MS Litwin JS Wolf Jr H Hricak CL Schuler DC Agerter PR Carroll, Urology 2001 57 604 10 10.1016/S0090-4295(01)00920-7 11306357
3. "Surveillance for recurrent bladder cancer using a point-of-care proteomic assay". HB Grossman M Soloway E Messing G Katz B Stein V Kassabian Y Shen, JAMA 2006 295 299 305 10.1001/jama.295.3.299 16418465
4. "Comparison of NMP22 BladderChek test and urine cytology for the detection of bladder cancer.". A Kumar R Kumar NP Gupta, Jpn J Clin Oncol 2006 36 172 175 10.1093/jjco/hyi244 16520358
5. "Utility of Serial Urinary Cytology in the Initial Evaluation of the Patient with Microscopic Hematuria.". K Nakamura A Kasraeian KA Iczkowski M Chang J Pendleton S Anai CJ Rosser, BMC Urology 2009 9 12 10.1186/1471-2490-9- 12 19744317
6. "Urine Cytology-Is it still the Gold Standard for Screening?". F Brown, Urol Clinics of North America 2000 27 1 25 37 10.1016/S0094-0143(05) 70231-7
7. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. EM Messing TB Young VB Hunt, et al. Urology 1995 45 387 10.1016/S0090-4295(99)80006-5 7879333
8. "Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis.". N Nese R Gupta MH Bui MB Amin, J Natl Compr Canc Netw 2009 7 1 48 57 19176205
9. "Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis.". MP Raitanen R Aine E Rintala J Kallio P Rajala H Juusela TL Tammela FinnBladder Group, Eur Urol 2002 41 3 284 9 10.1016/S0302-2838(02)00006-4 12180229
10. "Is urine cytology required for a hematuria evaluation.". CA Hofland AJ Marianai, J Uro 2004 171 1 324 326 10.1097/01.ju.0000100392.23046.17 (Pubitemid 37549157)
11. "The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma.". RA Badalament DK Hermansen M Kimmel H Gay HW Herr WR Fair WF Whitmore Jr MR Melamed, Cancer 1987 60 7 1423 7 10.1002/1097-0142(19871001)60:7<1423::AID- CNCR28206007023.0.CO;2-6 3304614
12. "Long-term outcome of home dipstick testing for hematuria.". R Madeb EM Messing, World J Urol 2008 26 1 19 24 10.1007/s00345-007-0224-1 18040694
13. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. GD Grossfeld JS Wolf Jr MS Litwan H Hricak CL Shuler DC Agerter, et al. Am Fam Physician 2001 63 1145 54 11277551